IMCAS Academy

Introduction
Program
Speakers
Sponsor list

GO BACK

IMCAS Americas 2022
Program

Adapt the schedule of the livestreamed class/congress to your time zone

Time zone reference: (UTC-05:00) America, Bogota

Time zone

Time zone:Change time zone

If you are logged in, change your default time zone in your account

FOCUS ON S077-078

IMCAS Alert - Injectable complications

Room: Room 1
Date: Saturday 23 July 2022 at 12:00 to 14:00
Format: CLINICAL CASE STUDY > unusual or difficult cases laid forth by experts followed by assessment of different treatment outcomes and patient care

Chairs

Dr Benjamin ASCHER

Plastic Surgeon

France

Dr Thomas RAPPL

Plastic Surgeon

Austria

Lectures of the session

Hours	Speakers	Lecture title	Abstract	Number
12:00	Dr Sergio TALARICO	How to increase safety when performing fillers	View	117258
12:12	Dr Peter VELTHUIS	The problem of filler complications: how bad is it?	View	115665
12:24		Presentation of the cases		115667
12:39	Dr Sergio TALARICO	Discussion by expert panelists		115670
12:39	Dr Matthieu BEUSTES STEFANELLI	Discussion by expert panelists		115666
12:39	Prof Maria Jose PELLI	Discussion by expert panelists		115668
12:39	Dr Alessio REDAELLI	Discussion by expert panelists		115672
12:39	Dr Hugues CARTIER	Discussion by expert panelists		117085
12:39	Dr Fernando FELICE	Discussion by expert panelist		117501
13:19	Dr Benjamin ASCHER	Simulator Injections Live - Danger zones explanation		117364
13:34		Final discussion and Q&A from audience		115673

Go to previous session

Go to next session

Recommended sessions

Complications

Fillers: HA (hyaluronic acid)

Skin lesions

Dr Sergio TALARICO

Dermatologist

Brazil

Other author(s) :

How to increase safety when performing fillers

Objectives: As the number of treatments performed with dermal fillers exponentially increases, complications that are rare, obviously also occur in greater numbers.
Therefore, it is very important to reinforce the measures that can help to avoid these situations that are at least unpleasant when not disastrous.
As in any medical act, success depends on: 1- the good evaluation and selection of the patient; 2- choice of the ideal product and the good practice of performing the procedure; 3- the ability of the performing physician.

Introduction: As the number of treatments performed with dermal fillers exponentially increases, complications that are rare, obviously also occur in greater numbers.

Therefore, it is very important to reinforce the measures that can help to avoid these situations that are at least unpleasant when not disastrous.

As in any medical act, we intend to demonstrate how to have success. It depends on the respect of: 1- the good evaluation and selection of the patient; 2- choice of the ideal product and the good practice of performing the procedure; 3- the ability of the performing physician

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Peter VELTHUIS

Dermatologist

Netherlands

Other author(s) : Tom Decates

The problem of filler complications: how bad is it?

Objectives: To understand the pathophysiology of filler complications.

Introduction: Different types of filler complications are seen. Over the past few years research at our university clinic has elucidated much of the background of these. Also the question whether a complication can be regarded as doctor-, patient- of filler-related is by and large been solved.

Materials / method: In the past 5 years almost 1200 new patients were referred to our out-patient clinic for filler complications. By systemically checking patient details and stratifying their problems we were able to understand much of the nature of their problems. In a number of patients biopsies from the filler material were analysed for both bacteria and immunological cells. Also every patient was analysed using ultrasound imaging.

Results: We found a correlation between complications and poor trained doctors. We established a new hypothesis about nature and treatment of vascular adverse events and non-inflammatory nodules with ultrasound imaging. We were able to assess the indicence of filler complications.

Conclusion: Resorbable filler complications are seldomly caused by the filler material, but mainly by less qualified doctors. Ultrasound imaging helps enormously in diagnosing and treating filler complications

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability